References
- 1. ACHAR SA, KUNDU S, NORCROSS WA. Diagnosis of acute coronary syndrome. American family physician 2005; 72(1): 119-26.
- 2. LIBBY P. Mechanisms of acute coronary syndromes and their implications for therapy. The New England journal of medicine 2013; 368(21): 2004–13.
- 3. ROSS R. Atherosclerosis – an inflammatory disease. The New England journal of medicine 1999; 340(2): 115–26.
- 4. ALAVI-MOGHADDAM M, PARSA-MAHJOOB M, GHODSSI-GHASSEMABADI R, BITAZAR B. Association of Admission Blood Glucose Level with Major Adverse Cardiac Events in Acute Coronary Syndrome; a Cohort Study. Archives of academic emergency medicine 2019; 7(1): e26.
- 5. BJARNASON TA, HAFTHORSSON SO, KRISTINSDOTTIR LB, OSKARSDOTTIR ES, JOHNSEN A, ANDERSEN K. The prognostic effect of known and newly detected type 2 diabetes in patients with acute coronary syndrome. Eur Heart J Acute Cardiovasc Care. 2020;9(6):608–615.
- 6. FIGUEIREDO VN, GODOI FC, MARTINS NS, QUINAGLIA E SILVA JC, NADRUZ W, JR., COELHO OR, et al. Diabetes mellitus unawareness is a strong determinant of mortality in patients manifesting myocardial infarction. Current medical research and opinion 2013; 29(11): 1423–7.
- 7. LENZEN M, RYDEN L, OHRVIK J, BARTNIK M, MALMBERG K, SCHOLTE OP REIMER W, et al. Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. European heart journal 2006; 27(24): 2969–74.
- 8. DZIEWIERZ A, GISZTEROWICZ D, SIUDAK Z, RAKOWSKI T, DUBIEL JS, DUDEK D. Admission glucose level and inhospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction. Clinical research in cardiology: official journal of the German Cardiac Society 2010; 99(11): 715–21.
- 9. UKENA C, DOBRE D, MAHFOUD F, KINDERMANN I, LAMIRAL Z, TALA S, et al. Hypo- and hyperglycemia predict outcome in patients with left ventricular dysfunction after acute myocardial infarction: data from EPHESUS. Journal of cardiac failure 2012; 18(6): 439–45.
- 10. BELLODI G, MANICARDI V, MALAVASI V, VENERI L, BERNINI G, BOSSINI P, et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. The American journal of cardiology 1989; 64(14): 885–8.
- 11. SEWDARSEN M, VYTHILINGUM S, JIALAL I, BECKER PJ. Prognostic importance of admission plasma glucose in diabetic and non-diabetic patients with acute myocardial infarction. The Quarterly journal of medicine 1989; 71(265): 461–6.
- 12. OSWALD GA, SMITH CC, BETTERIDGE DJ, YUDKIN JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. British medical journal (Clinical research ed) 1986; 293(6552): 917–22.
- 13. CHAKRABARTI AK, SINGH P, GOPALAKRISHNAN L, KUMAR V, ELIZABETH DOHERTY M, ABUEG C, et al. Admission Hyperglycemia and Acute Myocardial Infarction: Outcomes and Potential Therapies for Diabetics and Nondiabetics. Cardiol Res Pract 2012; 2012: 704314.
- 14. MALMBERG K, NORHAMMAR A, WEDEL H, RYDÉN L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99(20): 2626–32.
- 15. VAN DEN BERGHE G, WOUTERS P, WEEKERS F, VERWAEST C, BRUYNINCKX F, SCHETZ M, et al. Intensive insulin therapy in critically ill patients. The New England journal of medicine 2001; 345(19): 1359–67.
- 16. CAPES SE, HUNT D, MALMBERG K, GERSTEIN HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet (London, England) 2000; 355(9206): 773–8.
- 17. THYGESEN K, ALPERT JS, JAFFE AS, SIMOONS ML, CHAITMAN BR, WHITE HD, et al. Third Universal Definition of Myocardial Infarction. Journal of the American College of Cardiology 2012; 60(16): 1581–98.
- 18. CID-ALVAREZ B, GUDE F, CADARSO-SUAREZ C, GONZALEZ-BABARRO E, RODRIGUEZ-ALVAREZ MX, GARCIA-ACUNA JM, et al. Admission and fasting plasma glucose for estimating risk of death of diabetic and nondiabetic patients with acute coronary syndrome: nonlinearity of hazard ratios and time-dependent comparison. American heart journal 2009; 158(6): 989–97.
- 19. CORRADA E, CAPPELLERI A, BELLI G, GENOVESE S, BARBARO C, GASPARINI G, et al. Admission glycemia and markers of inflammation are independent outcome predictors in primary PCI in non-diabetic patients. Minerva cardioangiologica 2008; 56(5): 445–52.
- 20. ERGELEN M, UYAREL H, CICEK G, ISIK T, OSMONOV D, GUNAYDIN ZY, et al. Which is worst in patients undergoing primary angioplasty for acute myocardial infarction? Hyperglycaemia? Diabetes mellitus? Or both? Acta cardiologica 2010; 65(4): 415–23.
- 21. GOYAL A, MEHTA SR, DÍAZ R, GERSTEIN HC, AFZAL R, XAVIER D, et al. Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. Circulation 2009; 120(24): 2429–37.
- 22. HAO ZX, LIU Y, WANG DL, HAN WJ, WU L, LIU HL. Impact of Admission Glucose on Non-Diabetic Patients with ST-Segment Elevation Myocardial Infarction Treated with Percutaneous Coronary Intervention: A Meta-Analysis. Acta Cardiologica Sinica 2016; 32(2): 194–204.
- 23. ISHIHARA M, INOUE I, KAWAGOE T, SHIMATANI Y, KURISU S, NISHIOKA K, et al. Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. American heart journal 2003; 146(4): 674–8.
- 24. FOO K, COOPER J, DEANER A, KNIGHT C, SULIMAN A, RANJADAYALAN K, et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart (British Cardiac Society) 2003; 89(5): 512–6.
- 25. TIMMER JR, HOEKSTRA M, NIJSTEN MW, VAN DER HORST IC, OTTERVANGER JP, SLINGERLAND RJ, et al. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention. Circulation 2011; 124(6): 704–11.
- 26. NAITO R, MIYAUCHI K, OGITA M, KASAI T, KAWAGUCHI Y, TSUBOI S, et al. Impact of admission glycemia and glycosylated hemoglobin A1c on long-term clinical outcomes of non-diabetic patients with acute coronary syndrome. Journal of cardiology 2014; 63(2): 106–11.
- 27. DEEDWANIA P, KOSIBOROD M, BARRETT E, CERIELLO A, ISLEY W, MAZZONE T, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008; 117(12): 1610–9.
- 28. MALMBERG K, RYDÉN L, WEDEL H, BIRKELAND K, BOOTSMA A, DICKSTEIN K, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. European heart journal 2005; 26(7): 650–61.
- 29. CHEUNG NW, WONG VW, MCLEAN M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes care 2006; 29(4): 765–70.
- 30. WANG H, ZHANG Y, SHEN Z, FANG L, LIU Z, ZHANG S. Prognostic value of fasting glucose on the risk of heart failure and left ventricular systolic dysfunction in non-diabetic patients with st-segment elevation myocardial infarction. Front Med. 2021;15:70–78
- 31. WU H, LI R, WANG K, MU D, CHEN J-Z, WEI X, BAO X, WEI Z-H, XIE J, XU B. Predictive value of fasting blood glucose for microvascular obstruction in nondiabetic patients with st-segment elevation myocardial infarction after primary percutaneous coronary intervention. Cardiol Res Pract. 2020;2020:8429218-8429218
- 32. SANJUAN R, BLASCO ML, HUERTA R, PALACIOS L, CARRATALA A, NUNYEZ J, SANCHIS J. Insulin resistance and short-term mortality in patients with acute myocardial infarction. Int J Cardiol. 2014;172:e269–270
- 33. HANLEY AJ, WILLIAMS K, STERN MP, HAFFNER SM. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: The San Antonio heart study. Diabetes Care. 2002;25:1177–1184